Frailty in mouse ageing: A conceptual approach

Thomas von Zglinicki, Isabel Varela Nieto, Dora Brites, Niki Karagianni, Saida Ortolano, Spiros Georgopoulos, Ana Luisa Cardoso, Susana Novella, Gunter Lepperdinger, Anne-Ulrike Trendelenburg, Ronald van Os*

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

23 Citaten (Scopus)
292 Downloads (Pure)


Human life expectancy has increased dramatically in the last century and as a result also the prevalence of a variety of age-related diseases and syndromes. One such syndrome is frailty, which is defined as a combination of organ dysfunctions leading to increased vulnerability to adverse health outcomes. In humans, frailty is associated with various biomarkers of ageing and predicts relevant outcomes such as responses to therapies and progression of health status and mortality. Moreover, it is relatively easy to assess. To foster translation of mechanistic understanding of the ageing process and, importantly, of interventions that may extend healthy lifespan, frailty scales have been reverse translated into mice in recent years. We will review these approaches with a view to identify what is known and what is not known at present about their validity, reproducibility and reliability with a focus on the potential for further improvement. (C) 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license.

Originele taal-2English
Pagina's (van-tot)34-40
Aantal pagina's7
TijdschriftMechanisms of Ageing and Development
StatusPublished - dec-2016

Citeer dit